WHO ICTRP trial
Pharmacological and genetic imaging of executive function deficits
NL-OMON31059 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31059 |
|---|---|
| Public title | Pharmacological and genetic imaging of executive function deficits |
| Scientific title | Pharmacological and genetic imaging of executive function deficits - Pharmacological and genetic imaging of executive function deficits |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | psychische stoornissen: ontwikkelingsstoornissen (Autisme Spectrum Stoornissen) attention executive function deficits;10083624;10039628;attention;executive function deficits |
| Interventions | temporary, acute dopamine depletion by giving alpha-metyrosine (AMPT) ;dopamine;executive function deficits;fMRI;Metyrosine |
| Registration date | Sep 25, 2007 |
| Target size | 80 |
| Secondary IDs | 2007-004552-36;NL19245.018.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: